Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Genetics of multiple sclerosis: swimming in an ocean of data.
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis.
Amiloride: a molecular probe of sodium transport in tissues and cells.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Reactive astrocytes as therapeutic targets for CNS disorders.
Good Early Results for HERV Suppressor in MS
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study.
Vitamin D intake and incidence of multiple sclerosis.
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.
Immune status following alemtuzumab treatment in human CD52 transgenic mice.
Genmab Announces Ofatumumab Development Plans in RRMS and NMO
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
Multiple sclerosis.
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis.
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multipl

Pages